For many women, the menopausal transition can bring unwanted physical changes, including weight gain and an increase in abdominal fat. As interest in GLP-1 medications continues to grow, more women are exploring these treatments as a potential option for managing midlife weight gain and reducing excess body fat.
GLP-1s and Weight Management in Perimenopause
Weight gain is common during perimenopause and menopause, largely driven by hormonal changes — particularly declining estrogen. Estrogen plays a key role in regulating where the body stores fat, and as levels drop, fat tends to concentrate more around the midsection.
These hormonal shifts can also take a toll on cardiometabolic health. The menopausal transition often brings a slower metabolic rate, increased appetite, and sleep disturbances, which can further disrupt the hormones that regulate hunger and fullness.
As a result, diet and exercise alone may become less effective at managing the weight changes that often come with this stage of life. GLP-1 medications can offer an additional tool to support weight management during the menopausal transition.
How Do GLP-1 Medications Help Menopause Symptoms?
Menopause symptoms such as hot flashes, menstrual changes, sleep difficulties, and fatigue are largely driven by hormonal fluctuations. While GLP-1 medications are not FDA-approved to treat menopause symptoms and are not a substitute for hormone therapy when estrogen or progesterone deficiency is the underlying cause, they may offer several indirect benefits.
For some women, GLP-1 therapy may support overall metabolic health by reducing cravings, promoting weight loss, and improving certain cardiovascular risk factors. These changes may also contribute to an improved quality of life.
Beyond weight management, GLP-1 medications may offer several potential benefits for women during perimenopause and menopause:
- Reduction in visceral fat: Excess visceral, or abdominal, fat is associated with an increased risk of cardiovascular disease and type 2 diabetes. Reducing visceral fat may improve overall cardiometabolic health.
- Improved blood sugar control: Insulin resistance can become more common during the menopausal transition. GLP-1 medications can help regulate blood glucose levels and may improve insulin sensitivity.
- Potential cardiovascular benefits: Weight loss and improvements in metabolic health may positively affect factors such as cholesterol levels, blood pressure and inflammation, which are associated with cardiovascular risk.
Who Should Take GLP-s During Perimenopause?
Women navigating the transition from perimenopause to menopause may be good candidates for GLP-1 therapy. However, GLP-1 medications and hormone replacement therapy (HRT) should be used under the supervision of a qualified health care provider—ideally as part of a multidisciplinary care team. Treatment should be tailored to each individual’s needs, with regular follow-up and monitoring to ensure safety and effectiveness.
Finding the Treatment Plan That’s Right For You
The combination of GLP-1 therapy with HRT, in addition to lifestyle changes, can be a comprehensive approach for some women to counteract weight gain during menopause. As with all medications, it’s important to work closely with your practitioner to ensure you know the pros and cons and understand what lifestyle changes should be made in order to maximize the benefits and protect your overall physical and mental health.
If you’re interested in learning more, schedule a consultation to get started. Your GMS practitioner will create a personalized treatment plan that’s right for you and track your progress as well as changes in weight, energy, blood sugar, and symptoms. If you have been experiencing weight gain during menopause, it is not your fault. It is not a lack of willpower. And it is not too late.
Frequently Asked Questions
Can you take semaglutide during perimenopause?
Yes, you can safely take semaglutide during perimenopause as it can support weight management while also helping manage menopause symptoms.
Does menopause affect GLP-1 weight loss?
Yes, menopause can affect how your body responds to weight management, but GLP-1 medications such as semaglutide may still support weight loss and help reduce abdominal fat during this transition.
Can you take HRT and a GLP-1?
Yes, using GLP-1 medications alongside HRT is considered safe for many women. GLP-1s help regulate appetite and blood sugar, while hormone therapy may help address hormonal changes that affect energy and metabolism. Together, they may support fat loss while helping preserve lean muscle.
Is weight loss harder during perimenopause?
Yes, losing weight can become more challenging during perimenopause as hormonal fluctuations, changes in metabolism, and increased insulin resistance can affect how your body burns energy and stores fat.
Why is muscle preservation important after 40?
Preserving muscle after 40 is important because our bodies naturally begin a gradual decline in muscle mass and strength at a rate of about 3% to 8% per decade. Studies show that preserving muscle mass may help reduce the risk of chronic conditions such as diabetes, heart disease, and certain cancers.
